Magellan
Magellan - Allogeneic (Donor) Stem Cells
FromMagellan
Magellan is currently sponsoring clinical trials with the aim of seeking regulatory approval for the supply of ‘off the shelf’ stem cell treatments - using ‘donor stem cells’ - for the treatment of osteoarthritis.
Most popular related searches
stem cell
stem cell treatment
tissue cell
tissue cells
clinical trial
allogeneic cell
stem cell culturing
stem cell culture
surgical suction
surgery procedure
Allogeneic procedures (using ‘donor cells’), which allow for ‘off the shelf’ stem cell treatments, have three primary advantages:-
- Patients can be treated with especially selected ‘optimum’ stem cells re the treatment of a particular medical condition,
- Patients do not have to undergo a surgical (lipo-suction) procedure to obtain tissue/cells.
- Lower cost - the stem cells can be cultured/expanded in large volumes (rather than on a ‘one by one’ basis - as with autologous procedures - using each patient’s own cells).